Medlive Technology Co., Ltd. (2192.HK)

Growth (Per Share)

Revenue 5Y—
Revenue 3Y—
Earnings 5Y—
Earnings 3Y—
Dividend 5Y—
Dividend 3Y—

Capital Efficiency

ROIC—
ROE—
ROA—
ROTA—

Capital Structure

Market Cap5.46B
EV5.46B
Cash—
Current Ratio—
Debt/Equity—
Net Debt/EBITDA—
Show More

Select a metric from the list below to chart it

Income Statement
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Revenue
12.2
17.7
31.1
41.4
45.7
Revenue % Chg.
—
45.7%
75.6%
33.2%
10.4%
Cost of Revenue
4.9
6.5
8.3
12.2
14.8
Gross Profit
7.3
11.2
22.8
29.2
31.0
Gross Profit Margin
59.8%
63.5%
73.2%
70.6%
67.7%
R&D Expenses
1.8
2.2
2.3
—
—
Selling, General, & Admin Expenses
1.3
1.6
3.2
18.6
22.0
Other Expenses
1.8
2.0
2.2
-0.1
-1.2
Operating Income
2.4
5.5
15.1
10.2
19.6
Operating Income Margin
20.0%
31.3%
48.5%
24.7%
42.9%
Total Other Income/Expenses Net
-0.1
-0.1
0.2
-0.1
0.0
Income Before Tax
2.3
5.4
15.3
10.2
19.7
Income Before Tax Margin
19.2%
30.4%
49.1%
24.6%
43.0%
Income Tax Expense
0.3
0.8
2.9
3.6
1.3
Net Income
2.1
4.6
12.4
6.6
17.1
Net Income Margin
17.0%
25.7%
39.9%
15.9%
37.4%
Weighted Avg. Shares Out
690.2
690.2
690.2
616.0
—
EPS
0.0
0.0
0.0
0.0
—
EPS % Chg.
—
120.3%
164.9%
-45.1%
—
Weighted Avg. Shares Out Dil
690.2
690.2
690.2
635.8
—
EPS Diluted
0.0
0.0
0.0
0.0
—
Interest Income
0.0
0.0
0.1
1.1
9.6
Interest Expense
0.1
0.0
0.0
0.1
0.1
EBIT
2.3
5.4
15.3
11.2
29.2
EBIT Margin
18.7%
30.3%
49.2%
27.1%
63.9%
Depreciation & Amortization
0.6
0.7
0.8
0.9
1.3
EBITDA
2.9
6.1
16.1
12.1
30.5
EBITDA Margin
23.9%
34.2%
51.7%
29.3%
66.8%